Monterey Bio Acquisition ... (MTRYU)
NASDAQ: MTRYU
· Real-Time Price · USD
10.41
-0.54 (-4.93%)
At close: Sep 08, 2023, 3:39 PM
Company Description
Monterey Bio Acquisition Corporation does not have significant operations.
It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry.
The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021.
Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Monterey Bio Acquisition Corporation

Country | United States |
IPO Date | Oct 1, 2021 |
Industry | Shell Companies |
Sector | Financial Services |
Employees | n/a |
CEO | Murat Omur |
Contact Details
Address: 17 State Street New York City, New York United States | |
Website | https://www.montereybio.com |
Stock Details
Ticker Symbol | MTRYU |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001860663 |
CUSIP Number | 61240F207 |
ISIN Number | US61240F2074 |
Employer ID | 85-2204842 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Dr. Sanjeev Satyal Ph.D. | Chief Executive Officer |
Murat Omur | Chief Executive Officer |
Sean McGann | Chief Financial Officer |
William McKeever | Chief Financial Officer & Director |
Jonas Sven Magnus Grossman M.B.A. | Executive Chairman |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 30, 2022 | 8-K | Current Report |
Sep 08, 2022 | DEF 14A | Filing |
Aug 24, 2022 | PRE 14A | Filing |
Aug 11, 2022 | 10-Q | Quarterly Report |
May 13, 2022 | 10-Q | Quarterly Report |
Mar 29, 2022 | 10-K | Annual Report |
Feb 14, 2022 | SC 13G | Statement of acquisition of beneficial ownership b... |
Feb 14, 2022 | SC 13G | Statement of acquisition of beneficial ownership b... |
Feb 14, 2022 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Feb 07, 2022 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |